Geriatric assessment  was most often completed to describe a patient 's health and functional status .
Geriatric assessment  in the oncology setting is feasible , and some domains are associated with adverse outcomes .
However , there is limited evidence that geriatric assessment impacted treatment decision making .
BACKGROUND Geriatric assessment is a multidisciplinary diagnostic process that evaluates the older adult 's medical , psychological , social , and functional capacity .
No systematic review of the use of geriatric assessment in oncology has been conducted .
The goals of this systematic review were : 1 ) to provide an overview of all geriatric assessment instruments used in the oncology setting ; 2 ) to examine the feasibility and psychometric properties of those instruments ; and 3 ) to systematic ally evaluate the effectiveness of geriatric assessment in predicting or modifying outcomes ( including the impact on treatment decision making , toxicity of treatment , and mortality ) .
Obese frailty, physical performance deficits, and falls in older men with biochemical recurrence of prostate cancer on androgen deprivation therapy: a case-control study.
OBJECTIVES To test the hypothesis that early and rogen deprivation therapy ( ADT ) has no proven survival advantage in older men with biochemical recurrence ( BCR ) of prostate cancer ( PCa ) , and it may contribute to geriatric frailty . METHODS We conducted a case-control study of men aged 60 + years with BCR on ADT ( n = 63 ) vs PCa survivors without recurrence ( n = 71 ) .  Frailty prevalence , " obese " frailty , Short Physical Performance Battery ( SPPB ) scores , and falls were compared . An exploratory analysis of frailty biomarkers ( C-reactive protein , erythrocyte sedimentation rate , hemoglobin , albumin , and total cholesterol ) was performed . Summary statistics and univariate and multivariate regression analyses were conducted . RESULTS More patients on ADT  were obese ( body mass index > 30 ; 46.2 % vs 20.6 % ; P = .03 ) . There were no statistical differences in SPPB ( P = .41 ) or frailty ( P = .20 ) . Using a proposed " obese " frailty criteria , 8.7 % in ADT group were frail and 56.5 % were " prefrail , " compared with 2.9 % and 48.8 % of controls ( P = .02 ) . Falls in the last year were higher in the ADT group ( 14.3 % vs 2.8 % ; P = .02 ) . In analyses controlling for age , clinical characteristics , and comorbidities , the ADT group trended toward significance for " obese " frailty ( P = .14 ) and falls ( OR = 4.74 , P = .11 ) . Comorbidity significantly increased the likelihood of " obese " frailty ( P = .01 ) and falls ( OR 2.02 , P = .01 ) . CONCLUSIONS Men with BCR on ADT  are frailer using proposed modified " obese " frailty criteria . They may have lower performance status and more falls . A larger , prospect i ve trial is necessary to establish a causal link between ADT use and progression of frailty and disability
Geriatric assessment  was most often completed to describe a patient 's health and functional status .
Geriatric assessment  in the oncology setting is feasible , and some domains are associated with adverse outcomes .
However , there is limited evidence that geriatric assessment impacted treatment decision making .
BACKGROUND Geriatric assessment is a multidisciplinary diagnostic process that evaluates the older adult 's medical , psychological , social , and functional capacity .
No systematic review of the use of geriatric assessment in oncology has been conducted .
The goals of this systematic review were : 1 ) to provide an overview of all geriatric assessment instruments used in the oncology setting ; 2 ) to examine the feasibility and psychometric properties of those instruments ; and 3 ) to systematic ally evaluate the effectiveness of geriatric assessment in predicting or modifying outcomes ( including the impact on treatment decision making , toxicity of treatment , and mortality ) .